glp 1 agonist plants How GLP-1 Receptor Agonists Evolved from Diabetes to Weight Loss Treatments GLP-1-based therapies for type 2

Description

Nevertheless, factors such as supply challenges, restricted funding, high out-of-pocket costs and side effect fears could limit the uptake of the drugs, creating uncertainties around the future size and shape of demand

Therefore, localized delivery methods, such as intravitreal implants, nanoparticle carriers, or gene therapy aimed at retinal GLP-1R expression, are essential for maximizing therapeutic effectiveness while minimizing systemic exposure

(You can now subscribe to our Economic Times WhatsApp channel) (Catch all the Business News, Breaking News and Latest News Updates on The Economic Times.) Subscribe to The Economic Times Prime and read the ET ePaper online

Put plainly, when theres less body weight to maintain, the body does less work but it also becomes extra efficient, burning fewer calories than predicted and nudging weight back up